NCT02094703

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Symptomatic Non-complicated Urinary Tract Infection in Females

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 126 (estimated)
• Sponsor: Dr Cipto Mangunkusumo General Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The efficacy of Solifenacin Succinate 5 mg as adjuvant therapy and levofloxacin (500 mg) for short-term treatment to reduce symptoms in patients with symptomatic non complicated urinary tract infection in females.

Conditions

• Urinary Tract Infection

Interventions

Type	Name	Description
DRUG	Levofloxacin
DRUG	Solifenacin succinate
DRUG	Placebo (for Solifenacin succinate)

Timeline

• Start date: 2013-04-01
• Primary completion: 2014-11-01
• Completion: 2014-12-01
• First posted: 2014-03-24
• Last updated: 2014-03-24

Locations

1 site across 1 country: Indonesia